Tags

Type your tag names separated by a space and hit enter

New drugs. Azilsartan medoxomil, belimumab, and lurasidone hydrochloride.
J Am Pharm Assoc (2003). 2011 May-Jun; 51(3):444-7.JA

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Hussar DA
Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, USA.
Shah A
No affiliation info available

MeSH

Angiotensin II Type 1 Receptor BlockersAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntipsychotic AgentsBenzimidazolesHumansHypertensionIsoindolesLupus Erythematosus, SystemicLurasidone HydrochlorideOxadiazolesSchizophreniaThiazoles

Pub Type(s)

Journal Article

Language

eng

PubMed ID

21555300

Citation

Hussar, Daniel A., and Anokhi Shah. "New Drugs. Azilsartan Medoxomil, Belimumab, and Lurasidone Hydrochloride." Journal of the American Pharmacists Association : JAPhA, vol. 51, no. 3, 2011, pp. 444-7.
Hussar DA, Shah A. New drugs. Azilsartan medoxomil, belimumab, and lurasidone hydrochloride. J Am Pharm Assoc (2003). 2011;51(3):444-7.
Hussar, D. A., & Shah, A. (2011). New drugs. Azilsartan medoxomil, belimumab, and lurasidone hydrochloride. Journal of the American Pharmacists Association : JAPhA, 51(3), 444-7. https://doi.org/10.1331/JAPhA.2011.11522
Hussar DA, Shah A. New Drugs. Azilsartan Medoxomil, Belimumab, and Lurasidone Hydrochloride. J Am Pharm Assoc (2003). 2011 May-Jun;51(3):444-7. PubMed PMID: 21555300.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - New drugs. Azilsartan medoxomil, belimumab, and lurasidone hydrochloride. AU - Hussar,Daniel A, AU - Shah,Anokhi, PY - 2011/5/11/entrez PY - 2011/5/11/pubmed PY - 2011/9/8/medline SP - 444 EP - 7 JF - Journal of the American Pharmacists Association : JAPhA JO - J Am Pharm Assoc (2003) VL - 51 IS - 3 SN - 1544-3450 UR - https://www.unboundmedicine.com/medline/citation/21555300/New_drugs__Azilsartan_medoxomil_belimumab_and_lurasidone_hydrochloride_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1544-3191(15)30654-3 DB - PRIME DP - Unbound Medicine ER -